Cholesterol-lowering drugs called statins might be slowing the formation of certain kinds of cataracts in people taking the drugs.
Ophthalmologist Barbara E. Klein of the University of Wisconsin–Madison and her colleagues analyzed data from a vision study started in 1987. The participants received eye exams at the outset and every 5 years thereafter.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.